Waltham, MA, United States of America

David Freeman

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):

Title: The Innovations of David Freeman

Introduction

David Freeman is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate CDK9 activity. With a total of 2 patents to his name, Freeman's work is paving the way for advancements in cancer treatment.

Latest Patents

Freeman's latest patents focus on substituted pyrazolo[1,5-a]pyrimidines, which serve as inhibitors of CDK9. These compounds are designed to modulate CDK9 activity and are represented by a specific formula. The innovative nature of these inhibitors highlights Freeman's commitment to addressing critical challenges in medical science.

Career Highlights

Freeman is currently employed at Kronos Bio, Inc., where he continues to push the boundaries of drug discovery and development. His expertise in medicinal chemistry and pharmacology has positioned him as a key player in the industry.

Collaborations

Freeman collaborates with notable colleagues, including Peter Mikochik and Joseph P. Vacca. Their combined efforts contribute to the advancement of research and innovation within their field.

Conclusion

David Freeman's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions are not only significant in terms of patents but also in their potential impact on cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…